Академический Документы
Профессиональный Документы
Культура Документы
Regd.Off:4KMSTONEBERICHHARAROAD,TEHSILBAHADURGARH
DISTTJHAJJAR,HARYANA124507
CIN:L01122HR1996PLC033029
Tele :- +91-9811341542
Email : genomicvalley@gmail.com
Visit : http://www.genomicvalley.com
GENOMICVALLEYBIOTECHLIMITED
Regd.Off:4KMSTONEBERICHHARAROAD,TEHSILBAHADURGARH
DISTTJHAJJAR,HARYANA
CIN:L01122HR1996PLC033029
GenomicValleyBiotechLimitedtodayreporteditsfinancialperformanceforthequarterandhalfyearended
30September2016
Highlightsoftheunauditedfinancialresultsascomparedtothepreviousyearare:
PARTI
Sr.No.
Particular
30Sep16
Unaudited
2
(a)
(b)
(c)
(d)
(e)
(f)
3
4
5
6
7
8
9
10
11
12
13
14
15
PartI
IncomeFromOperations
a)NetSales/IncomeFromOperations(Netofexciseduty)
b)OtherOperatingIncome
Totaincomefromoperation(net)
Expenses
Costofmaterialsconsumed
PurchasesofStockinTrade
Changesininventoriesoffinishedgoodsworkinprogressand
StockinTrade
Employeebenefitsexpense
Depreciationandamortizationexpense
QuarterEnded
30Jun16
Unaudited
30Sep15
Unaudited
(Amountin)
HalfYearEnded
30Sep16
30Sep15
Unaudited
Unaudited
YearEnded
31Mar16
Audited
Otherexpenses(Anyitemexceeding10%ofthetotalexpenses
relatingtocontinuingoperationtobeshownseprately
3,91,824.68 3,87,065.20 8,82,355.42 7,78,889.88 18,74,872.72 36,19,174.72
TotalExpenses
16,84,738.54 10,02,789.80 19,51,289.09 26,87,528.34 33,88,990.06 61,88,234.40
Profit/(Loss)fromoperationsbeforeotherincome,finance
costsandexceptionalitem
OtherIncome
Profit/lossfromordinaryactivitybeforefinancialcost&
exceptionalitems(34)
Financialcost
Profitfromordinaryactivityafterfinancialcostbutbefore
exceptionitem
ExceptionalItem
ProfitFromordinaryactivitiesbeforetax
Taxexpenses
NetProfit/(Loss)fromordinaryactivitiesaftertax
Extraordinaryitem
Netprofit/(Loss)fortheperiod
PaidupEquityShareCapital,EquityShareof10/each
ReservesexcludingRevaluationReserveasperbalancesheetof
previousaccountingyear
EarningPerShare
(a)Basic
(b)Diluted
6,19,538.54
6,19,538.54
6,19,538.54
30,54,500.00
64,182.37
64,182.37
64,182.37
64,182.37
30,54,500.00
15,40,696.23
15,40,696.23
15,40,696.23
15,40,696.23
30,54,500.00
5,55,356.17
5,55,356.17
5,55,356.17
5,55,356.17
30,54,500.00
17,69,229.18
17,69,229.18
17,69,229.18
17,69,229.18
30,54,500.00
34,48,425.67
34,48,425.67
1,00,600.00
33,47,825.67
33,47,825.67
30,54,500.00
150,85,115.86
0.20
0.20
150,85,115.86
0.02
0.02
184,32,941.53
0.50
0.50
150,85,115.86
0.18
0.18
184,32,941.53
0.58
0.58
150,85,115.86
1.10
1.10
PARTII
Sr.No.
QuarterEnded
30Jun16
Unaudited
Particular
30Sep16
Unaudited
PARTICULAROFSHAREHOLDING
1 PublicShareholding
NumberofShares
PercentageofShareholding
2 PromotersandPromotersGroupShareholding
a)Pledge/Encumbered
NumberofShares
PercentageofShares(asa%ofthetotalShareholdingof
PromoterandPromoterGroup)
PercentageofShares(asa%ofthetotalsharecapialofthe
Company)
b)Nonencumbered
NumberofShares
PercentageofShares(asa%ofthetotalShareholdingofthe
promoterandpromoterGroup)
PercentageofShares(asa%ofthetotalShareCapitalofthe
Company)
INVESTORCOMPLAINT
PARTICULAR
Pendingatthebeginningofthequarter
Receivedduringthequarter
Disposedofduringthequarter
Remainingunresolvedattheendofthequarter
HalfYearEnded
30Sep16
30Sep15
Unaudited
Unaudited
30Sep15
Unaudited
YearEnded
31Mar16
Audited
100.00%
100.00%
100.00%
100.00%
100.00%
64.22%
64.22%
64.22%
64.22%
64.22%
64.22%
3Monthended 30Sep16
0
0
0
0
Particulars
I.
Figures as at the
end of 31.03.2016
305,45,000.00
145,29,759.69
0.00
450,74,759.69
305,45,000.00
150,85,115.86
0.00
456,30,115.86
3 Non-Current Liabilities
(a)
LongTermborrowings
(b)
Deferred Tax Liabilities (Net)
(c)
OtherLongTermLiabilities
(d)
LongTermProvisions
Total Non-Current Liabilities
75,00,000.00
0.00
0.00
0.00
75,00,000.00
75,00,000.00
0.00
0.00
0.00
75,00,000.00
4 Current Liabilities
(a)
ShortTermBorrowings
(b)
Trade Payables
(c)
OtherCurrentLiabilities
(d)
ShortTermProvisions
Total Non-Current Liabilities
0.00
0.00
92,59,874.38
1,39,000.00
93,98,874.38
0.00
0.00
71,99,359.00
1,39,000.00
73,38,359.00
TOTAL
619,73,634.07
604,68,474.86
Non-Current Assets
1 (a)
Fixedassets
(i)
Tangible assets
(ii) Intangible assets
(iii) Capital work-in-progress
(iv) Intangible assets under development
NonCurrentInvestments
(b)
Deferred Tax Assets (Net)
(c)
LongTermLoansandAdvances
(d)
OtherNonCurrentAssets
(e)
Total Non-Assets
353,73,241.44
0.00
0.00
0.00
0.00
1,04,915.07
242,80,000.00
0.00
597,58,156.51
317,56,398.90
0.00
0.00
0.00
11,31,790.00
1,04,915.07
251,00,000.00
0.00
580,93,103.97
2 Current Assets
CurrentInvestments
(a)
(b)
Inventories
(c)
TradeReceivables
(d)
CashandCashEquivalents
(e)
ShortTermLoansandAdvances
(f)
OtherCurrentAssets
Total Current Assets
0.00
5,51,230.00
0.00
47,697.56
0.00
16,16,550.00
22,15,477.56
0.00
0.00
0.00
96,672.39
0.00
22,78,698.50
23,75,370.89
TOTAL
619,73,634.07
604,68,474.86
II.
ASSETS
Notes:
1)
2)
3)
The above result were reviewed by Audit Committee and were thereafter approved by Board of Director of the
Companyattheirrespectivemeetingheldon12thNovember,2016.
Taxexpensesincludesprovisionforcurrenttax&defferedtax.
Previous period's figures have been regrouped/rearranged wherever necessary to make their classification
comparablewiththecurrentperiod.
ForandonbehalfoftheBoardofGenomicValleyBiotechLtd
Place:
Date:
Delhi
12112016
YogeshAgrawal
ManagingDirector
DIN01165288
Add:G74PushkarEnclave
PaschimVihar,NewDelhi110063